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c o n c i s e c o m m u n i c a t i o n
An Outbreak of Pneumococcal
Pneumonia Among Residents
of a Retirement Home in France
During October 2003
Y. Hansmann, MD; A. Doyle, MPhil; V. Remy, MD;
B. Jaulhac, MD, PhD; D. Christmann, MD;
O. Lesens, MD; A. Perrocheau, MD
We describe an outbreak of pneumonia due to Streptococcus pneu-
moniae in a French retirement home. Eleven residents developed
pneumonia. Eight patients had positive results of urinary antigen
tests. There were no further cases after the implementation of control
measures, which involved isolation of and receipt of antibiotic ther-
apy by symptomatic residents. No risk factors for transmission of
S. pneumoniae were identified in this population.
Infect Control Hosp Epidemiol 2006; 27:1252-1254
Streptococcus pneumoniae is the main cause of bacterial pneu-
monia, particularly among elderly persons,1 with a reported
case-fatality rate of 40% among persons with bacteremia. S.
pneumoniae usually colonizes the upper respiratory tract, a site
from which it can be transmitted from person to person.2
Outbreaks of severe infection due to S. pneumoniae in retire-
ment homes and long-term care geriatric wards have been
described elsewhere.3-7 We present the results of the investi-
gation of an outbreak of pneumonia due to S. pneumoniae
serotype 4 that occurred in a French retirement home during
October 2003 and describe the control measures implemented.
methods
We defined a case patient as any resident or staff member of
the retirement home in whom pneumonia due to S. pneu-
moniae serotype 4 was detected between September 29 and
October 30, 2003. All case patients had a temperature greater
than 38C, at least 1 respiratory symptom (cough, unusual
expectoration, dyspnea, thoracic pain, and/or localized pul-
monary signs on auscultation), and radiographic evidence of
pneumonia in the absence of another cause. For epidemio-
logical and clinical investigation, radiography was systemat-
ically done for all patients who had at least 1 respiratory
symptom or fever. Among them, the patients with signs of
focal consolidation or pleural effusion were tested for S. pneu-
moniae urinary antigens (Binax NOW pneumonia kit; Ox-
oid). To exclude false-positive results for patients with pre-
vious pneumococcal infection, all patients who had a positive
result of the urinary antigen test were questioned about their
history of other respiratory infections in the past 6 months.
To eliminate other causes of pneumonia, the latter subgroup
of patients underwent serological testing for detection of an-
tibodies specific to Legionella pneumophila, Mycoplasma pneu-
moniae, and Chlamydia pneumoniae during the acute phase
of the outbreak and 4 weeks after the start of symptoms.
Oropharyngeal swab specimens were obtained from all res-
idents and staff members for detection of S. pneumoniae col-
onization. Culture of the oropharyngeal sample was done on
both blood agar and gentamicin blood agar within 2 hours
after sampling. All microbiological tests were performed at
the bacteriology laboratory of Strasbourg University Hospital
(Strasbourg, France). The S. pneumoniae strains isolated from
samples obtained from the residents and staff members were
sent to the national reference center for serotyping with spe-
cific antisera provided by the Statens Seruminstitut (Copen-
hagen, Denmark).
A retrospective cohort study was conducted to describe the
outbreak and to investigate risk factors for transmission of
the pathogenic strain and acquisition of S. pneumoniae in-
fection. Data were collected from individual medical records
at the retirement home, and when necessary, the clinicians
in charge of case patients (especially those who had lived in
the retirement home for less than 5 years) were questioned.
results
On October 16, 2003, a health warning was sent to local
health authorities after 3 residents from the same retirement
home in Strasbourg were hospitalized for severe pneumonia.
The retirement home housed 94 residents, of whom 85 (90%)
were women. The mean age (SD) of the residents was 86
 1 years (range, 55-97 years). The residents’ bedrooms were
situated on 5 floors. No staff members were concurrently
employed by other healthcare facilities.
Medical examinations were performed for all residents on
October 17. The 41 residents who presented with fever or at
least 1 symptom of respiratory infection were placed under
droplet isolation precautions and treated for 6 days with
amoxicillin (1 g 3 times per day) or with levofloxacin (500
mg once per day) if allergic to penicillin. On October 22, the
23-valent pneumococcal vaccine (without influenza vaccine)
was administered to all residents and all staff members who
chose to receive it who did not have respiratory symptoms.
No further cases of pneumonia occurred once the control
measures were implemented (Figure).
Eleven patients received a diagnosis of pneumonia between
October 13 and 17, for an attack rate of 11.7% (Figure). All
case patients were female residents (mean age, of 86 years).
Three of the 11 case patients died during the study period;
2 died from S. pneumoniae infection, for a case-fatality rate
of 18.2%. The clinical characteristics and microbiological
findings for the case patients are shown in the Table. Results
of serological tests for detection of L. pneumophila, M. pneu-
moniae, and C. pneumoniae were negative for all patients.
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figure. Epidemic curve of an outbreak of pneumococcal pneu-
monia among residents at a French retirement home during October
2003, showing the date of symptom onset. See Methods for the
definition of “case patient” and description of the control measures
implemented. Pneumo 23, 23-valent pneumococcal vaccine.
table. Demographic and Clinical Characteristics of Retirement Home Residents With Pneumococcal Infection, Strasbourg, France,
October 2003.
Case
patient Age, y Initial symptom(s)
Highest
temperature, C
Specimen(s) with a
positive test result, by test type
Hospitalized Died
S. pneumoniae
culture
Pneumococcal
antigen test
1 79 Shock 38.8 Blood, TA Not done Yes Yes
3 95 Cough 37 None Urine No No
4 91 Dyspnea, expectoration 39 Blood, sputum Urine Yes No
6 83 Chills 37 Blood Urine Yes No
7 88 Dyspnea 37.5 TA Urine Yes No
8 84 Dyspnea 38.4 TA Urine Yes No
9 88 Dyspnea, respiratory distress 39 TA Urine Yes Yes
10 79 Neurological symptoms, meningitis 39.7 Blood, TA Urine, CSF Yes Yes
11 85 Dyspnea, productive cough 38.1 None Urine Yes No
2 82 Cough 39 None Nonea No No
5 94 Cough 38.2 None Nonea No No
note. See Methods for the definition of “case patient.” CSF, cerebrospinal fluid; S. pneumoniae, Streptococcus pneumoniae serotype 4; TA, tracheal aspirate.
a Urine specimens tested negative for pneumococcal antigen.
S. pneumoniae serotype 4 was recovered from 1 of the 83
healthy residents for whom oropharyngeal samples were cul-
tured. Thirty-one of these residents had previously been
treated with antibiotics.
Investigation of contact between case patients in the re-
tirement home revealed that 6 had neither participated in
group activities nor shared a dining table with another case
patient. One of these 6 case patients was the only case patient
living on the first floor of the retirement home and, therefore,
had no known direct contact with the other case patients.
However, 4 case patients participated in the same singing and
music group on October 8.
The attack rate varied according to the floor of residence,
from 9.1% on the third floor to 25% on the fifth floor (P 1
.5). None of the factors investigated in the cohort analysis (age,
comorbidities, inability to perform activities of daily living, use
of common areas, and participation in group activities) were
identified as risk factors for pneumococcal pneumonia.
Only 1 case patient had received the 23-valent pneumo-
coccal vaccine in the past 3 years. All patients were vaccinated
against influenza after the outbreak, in October 2003.
discussion
We have described an outbreak of infections caused by S.
pneumoniae among residents of a French retirement home.
This epidemic was promptly detected by the alertness of the
staff, allowing rapid introduction of control measures (droplet
isolation precautions and antibiotic treatment of symptomatic
residents). Rapid identification of outbreaks, prompt imple-
mentation of preventive measures, and use of effective treat-
ments are essential, given the gravity and risk of transmission
of S. pneumoniae among institutionalized elderly persons.3-7
It is possible that the frequency of outbreaks of infection
due to S. pneumoniae is underestimated because of the dif-
ficulty in making diagnoses on the basis of microbiological
findings. Detection of the bacteria causing pneumonia is com-
plicated by the difficulty in obtaining high-quality samples
(eg, 50%-70% of institutionalized residents cannot expec-
torate1). For this reason, we performed urinary antigen tests,
as well as typical microbiological tests, for detection of S.
pneumoniae antigens. In this investigation, the urinary an-
tigen test, used in association with clinical diagnosis, im-
proved our ability to diagnose pneumococcal infection and
was the only means of S. pneumoniae identification for 2 of
the 11 case patients. The published sensitivity for this test
varies from 62.5% to 87% for adults with pneumonia caused
by S. pneumoniae.8,9 The specificity of the test is reported to
be quite variable for adults, with reported values ranging from
60% to 97% (depending the method used),8,9 but a lower
specificity is observed for children, especially if they are col-
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onized with S. pneumoniae.10 However, the urinary antigen
test can yield positive results soon after the onset of infection
and can be useful for the rapid detection of cases in outbreaks
caused by S. pneumoniae, thus helping to speed up decisions
about therapeutic and preventive treatment.
No additional cases were observed after the implementa-
tion of isolation measures and use of preemptive antibiotic
treatment. These measures were limited to residents with re-
spiratory symptoms, to limit the prescription of antibiotics
and, hence, the risk of adverse effects. A rational antibiotic
use policy can be part of the management of an outbreak,
but a strict protocol based on factors such as antibiotic class,
indications for use, and early administration to the at-risk
population must be used. Hygiene precautions, including
droplet isolation of patients with respiratory signs during an
epidemic, are key factors in preventing transmission of re-
spiratory pathogens, especially in nearly closed communities,
such as retirement homes for elderly patients.
Outbreaks such as the one described here call into question
the role of vaccination in primary prevention of bacteremic
pneumoniae or invasive disease. In 1999, the World Health
Organization recommended vaccination with the 23-valent
polysaccharide vaccine for patients with risk factors for pneu-
mococcal infections, especially for patients older than 65 years
of age.11 The effectiveness of vaccination in preventing invasive
disease or death during this outbreak could not be evaluated,
as too few residents had been vaccinated before the outbreak.
A low level of vaccine coverage has often been associated with
outbreaks involving elderly patients.4,6 Case-control studies
have shown that antipneumococcal vaccination confers pro-
tection against invasive pneumococcal infections.12 Random-
ized trials have not succeeded in demonstrating the efficacy of
vaccination against nonbacteremic pneumonia nor its bene-
ficial impact on mortality among elderly patients.13 However,
vaccination remains the only preventive action against pneu-
mococcal infection and, consequently, against pneumococcal
epidemics in retirement homes for elderly persons.
Pneumococcal infections can have serious consequences in
elderly persons, and it is important that outbreaks in pop-
ulations of elderly persons are promptly managed. We rec-
ommend isolation of and antibiotic therapy for elderly per-
sons with respiratory symptoms.
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